MedTrace Logo

Development of a Blood Test for Marfan Syndrome

NCT02148900 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 336

Last updated 2017-01-05

No results posted yet for this study

Summary

The objective of this study is to determine whether a simple blood test can be a useful clinical tool for monitoring aortic disease in Marfan syndrome and Marfan-related disorders.

Conditions

  • Marfan Syndrome
  • Marfan Related Disorders
  • Control Subjects

Sponsors & Collaborators

  • Oregon Health and Science University

    collaborator OTHER

  • University of Utah

    collaborator OTHER

  • The University of Texas Health Science Center, Houston

    collaborator OTHER

  • Shriners Hospitals for Children

    lead OTHER

Principal Investigators

  • Lynn Y. Sakai, Ph.D. · Shriners Hospitals for Children

Eligibility

Min Age
4 Years
Max Age
26 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02148900 on ClinicalTrials.gov